Skip to content

Clinical trials

Observational Hyperoxaluria, Primary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperoxaluria, Primary Phase: Observational Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20091
20133
20162
20171
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic7
Centre Hospitalier Universitaire de Liege1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
NYU Langone Health1
UK Kidney Association1
University Hospital, Strasbourg, France1
VA New York Harbor Healthcare System1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperoxaluria, Primary14
Hyperoxaluria7
Cystinuria6
Dent Disease6
Nephrocalcinosis3
Cystinosis2
Diabetes Insipidus, Nephrogenic2
Kidney Calculi2
Nephritis, Hereditary2
Oculocerebrorenal Syndrome2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.